Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease
- 15 May 2006
- Vol. 92 (10) , 1518-1519
- https://doi.org/10.1136/hrt.2005.082313
Abstract
The objective of this study was to investigate whether NT-proBNP predicts mortality in a group of patients with ESRD. The secondary end point was to examine differences in patients with and without raised NT-proBNP, according to the cut-off value that best predicted mortality.Keywords
This publication has 5 references indexed in Scilit:
- Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidatesEuropean Heart Journal - Cardiovascular Imaging, 2005
- N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Coronary Disease and Left Ventricular Hypertrophy in Asymptomatic CKD Not Requiring DialysisAmerican Journal of Kidney Diseases, 2005
- The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) studyThe American Journal of Cardiology, 2005
- Multi-Biomarker Risk Stratification of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Cardiac Troponin T and I in End-Stage Renal Disease for All-Cause DeathClinical Chemistry, 2004
- Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rateEuropean Journal of Heart Failure, 2003